The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments

Prostate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on...

Descripción completa

Detalles Bibliográficos
Autores: Cantarero Prieto, David|||0000-0001-8082-0639, Lera Torres, Javier Isaac|||0000-0002-0367-265X, Lanza León, Paloma|||0000-0002-0369-180X, Barreda Gutiérrez, Marina|||0000-0002-5952-6758, Guillem Porta, Vicente, Castelo Branco, Luis, Martín Moreno, José María
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/28278
Acceso en línea:https://hdl.handle.net/10902/28278
Access Level:acceso abierto
Palabra clave:Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
id ES_cddf533d786d85e443d54bfcc8d22053
oai_identifier_str oai:repositorio.unican.es:10902/28278
network_acronym_str ES
network_name_str España
repository_id_str
spelling The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatmentsCantarero Prieto, David|||0000-0001-8082-0639Lera Torres, Javier Isaac|||0000-0002-0367-265XLanza León, Paloma|||0000-0002-0369-180XBarreda Gutiérrez, Marina|||0000-0002-5952-6758Guillem Porta, VicenteCastelo Branco, LuisMartín Moreno, José MaríaEconomic burdenCost of illnessCost-effectiveness analysisLocalized prostate cancerProstate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on this challenge by characterizing the economic burden and cost-effectiveness of different treatment strategies for localized prostate cancer after analyzing published comparable data from studies conducted in OECD countries.MDPIUniversidad de Cantabria20222022-08-24journal articlehttp://purl.org/coar/resource_type/c_6501NAhttp://purl.org/coar/version/c_be7fb7dd8ff6fe43info:eu-repo/semantics/articlehttps://hdl.handle.net/10902/28278Cancers, 2020, 14(17), 4088reponame:UCrea Repositorio Abierto de la Universidad de Cantabriainstname:Universidad de Cantabria (UC)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositorio.unican.es:10902/282782026-06-02T12:39:31Z
dc.title.none.fl_str_mv The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
title The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
spellingShingle The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
Cantarero Prieto, David|||0000-0001-8082-0639
Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
title_short The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
title_full The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
title_fullStr The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
title_full_unstemmed The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
title_sort The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments
dc.creator.none.fl_str_mv Cantarero Prieto, David|||0000-0001-8082-0639
Lera Torres, Javier Isaac|||0000-0002-0367-265X
Lanza León, Paloma|||0000-0002-0369-180X
Barreda Gutiérrez, Marina|||0000-0002-5952-6758
Guillem Porta, Vicente
Castelo Branco, Luis
Martín Moreno, José María
author Cantarero Prieto, David|||0000-0001-8082-0639
author_facet Cantarero Prieto, David|||0000-0001-8082-0639
Lera Torres, Javier Isaac|||0000-0002-0367-265X
Lanza León, Paloma|||0000-0002-0369-180X
Barreda Gutiérrez, Marina|||0000-0002-5952-6758
Guillem Porta, Vicente
Castelo Branco, Luis
Martín Moreno, José María
author_role author
author2 Lera Torres, Javier Isaac|||0000-0002-0367-265X
Lanza León, Paloma|||0000-0002-0369-180X
Barreda Gutiérrez, Marina|||0000-0002-5952-6758
Guillem Porta, Vicente
Castelo Branco, Luis
Martín Moreno, José María
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidad de Cantabria
dc.subject.none.fl_str_mv Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
topic Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
description Prostate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on this challenge by characterizing the economic burden and cost-effectiveness of different treatment strategies for localized prostate cancer after analyzing published comparable data from studies conducted in OECD countries.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-08-24
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
NA
http://purl.org/coar/version/c_be7fb7dd8ff6fe43
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10902/28278
url https://hdl.handle.net/10902/28278
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv Cancers, 2020, 14(17), 4088
reponame:UCrea Repositorio Abierto de la Universidad de Cantabria
instname:Universidad de Cantabria (UC)
instname_str Universidad de Cantabria (UC)
reponame_str UCrea Repositorio Abierto de la Universidad de Cantabria
collection UCrea Repositorio Abierto de la Universidad de Cantabria
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419894882172928
score 15,300719

Similares en LA Referencia